BNC Korea Co, Ltd Logo

BNC Korea Co, Ltd

256840 | KO

Overview

Corporate Details

ISIN(s):
KR7256840000
LEI:
Country:
South Korea
Address:
대구광역시 달서구 성서공단로11길 62 대구테크노파크 벤처공장 1호관 405호(사무실),502호, 503호, 206호, 대구광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
Legal Proceedings Report
기타경영사항(자율공시) (의약품 회수·폐기 및 잠정 제조중지 등 명령 취소 소송 1심 판결)
Korean 10.7 KB
2025-08-26 00:00
Regulatory Filings
투자판단관련주요경영사항 (CL-N, N 중국 국가약품감독관리국(NMPA) 품목허가 획득)
Korean 12.6 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 2.1 MB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-07-21 00:00
Regulatory Filings
투자판단관련주요경영사항 (Cutegel 중국 국가약품감독관리국(NMPA) 품목허가 획득)
Korean 8.4 KB
2025-07-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 107.0 KB
2025-05-30 00:00
Regulatory Filings
기타경영사항(자율공시)
Korean 6.4 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-04-29 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.5 KB
2025-04-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 107.2 KB
2025-03-31 00:00
AGM Information
정기주주총회결과
Korean 19.9 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 25.3 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 2.1 MB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 195.0 KB
2025-03-12 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 195.4 KB

Automate Your Workflow. Get a real-time feed of all BNC Korea Co, Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BNC Korea Co, Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BNC Korea Co, Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Mineralys Therapeutics, Inc. Logo
Developing targeted treatments for hypertension & CKD driven by elevated aldosterone.
United States of America
MLYS
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
MiNK Therapeutics, Inc. Logo
Developing allogeneic iNKT cell therapies for cancer and immune-mediated diseases.
United States of America
INKT
MIRA PHARMACEUTICALS, INC. Logo
Develops novel ketamine and THC analogs for neurologic and neuropsychiatric disorders.
United States of America
MIRA
Mirum Pharmaceuticals, Inc. Logo
Develops and commercializes therapies for rare, debilitating liver diseases in children and adults.
United States of America
MIRM
Mithra Pharmaceuticals S.A. Logo
Biotech firm developing pharma for women's health: contraception, fertility, and menopause.
Belgium
MITRA
MIZUHO MEDY CO.,LTD. Logo
Develops rapid diagnostic tests & gene analyzers for clinical, research & agricultural markets.
Japan
4595
MOA Life Plus Co. Ltd. Logo
Develops immunotherapies & consumer solutions for immunity, skin rejuvenation, and pet care.
South Korea
142760
Moberg Pharma Logo
Develops & commercializes a leading topical treatment for nail fungus for European markets.
Sweden
MOB
Mochida Pharmaceutical Co.,Ltd. Logo
An R&D-driven company making drugs, skincare, and medical equipment for specialized fields.
Japan
4534

Talk to a Data Expert

Have a question? We'll get back to you promptly.